HEADER CHAPERONE 28-JUN-07 2QG0
TITLE HSP90 COMPLEXED WITH A943037
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: HEAT SHOCK PROTEIN HSP 90-ALPHA;
COMPND 3 CHAIN: A, B;
COMPND 4 SYNONYM: HSP 86, RENAL CARCINOMA ANTIGEN NY- REN-38;
COMPND 5 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 GENE: HSP90AA1, HSP90A, HSPC1, HSPCA;
SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI
KEYWDS PROTEIN-INHIBITOR COMPLEX, CHAPERONE
EXPDTA X-RAY DIFFRACTION
AUTHOR C.H.PARK
REVDAT 3 30-AUG-23 2QG0 1 REMARK
REVDAT 2 24-FEB-09 2QG0 1 VERSN
REVDAT 1 01-JUL-08 2QG0 0
JRNL AUTH J.R.HUTH,C.PARK,A.M.PETROS,A.R.KUNZER,M.D.WENDT,X.WANG,
JRNL AUTH 2 C.L.LYNCH,J.C.MACK,K.M.SWIFT,R.A.JUDGE,J.CHEN,
JRNL AUTH 3 P.L.RICHARDSON,S.JIN,S.K.TAHIR,E.D.MATAYOSHI,S.A.DORWIN,
JRNL AUTH 4 U.S.LADROR,J.M.SEVERIN,K.A.WALTER,D.M.BARTLEY,S.W.FESIK,
JRNL AUTH 5 S.W.ELMORE,P.J.HAJDUK
JRNL TITL DISCOVERY AND DESIGN OF NOVEL HSP90 INHIBITORS USING
JRNL TITL 2 MULTIPLE FRAGMENT-BASED DESIGN STRATEGIES.
JRNL REF CHEM.BIOL.DRUG DES. V. 70 1 2007
JRNL REFN ISSN 1747-0277
JRNL PMID 17630989
JRNL DOI 10.1111/J.1747-0285.2007.00535.X
REMARK 2
REMARK 2 RESOLUTION. 1.85 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : CNX 2002
REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE-
REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU,
REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS
REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA,
REMARK 3 : YIP,DZAKULA)
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.85
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.86
REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.000
REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 198646.200
REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000
REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 97.3
REMARK 3 NUMBER OF REFLECTIONS : 45359
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.241
REMARK 3 R VALUE (WORKING SET) : 0.229
REMARK 3 FREE R VALUE : 0.285
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.100
REMARK 3 FREE R VALUE TEST SET COUNT : 4563
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.004
REMARK 3
REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA.
REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL
REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL
REMARK 3 FREE R VALUE (NO CUTOFF) : NULL
REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL
REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL
REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL
REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 46630
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 10
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.85
REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.92
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 93.70
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3914
REMARK 3 BIN R VALUE (WORKING SET) : 0.2260
REMARK 3 BIN FREE R VALUE : 0.2850
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 9.80
REMARK 3 BIN FREE R VALUE TEST SET COUNT : 424
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.014
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 3254
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 54
REMARK 3 SOLVENT ATOMS : 1131
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 13.20
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 19.60
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : 1.71000
REMARK 3 B22 (A**2) : -1.26000
REMARK 3 B33 (A**2) : -0.44000
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 1.23000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.23
REMARK 3 ESD FROM SIGMAA (A) : 0.05
REMARK 3 LOW RESOLUTION CUTOFF (A) : 6.00
REMARK 3
REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.30
REMARK 3 ESD FROM C-V SIGMAA (A) : 0.13
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.005
REMARK 3 BOND ANGLES (DEGREES) : 1.200
REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.70
REMARK 3 IMPROPER ANGLES (DEGREES) : 0.690
REMARK 3
REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA
REMARK 3 MAIN-CHAIN BOND (A**2) : 0.760 ; 1.500
REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.210 ; 2.000
REMARK 3 SIDE-CHAIN BOND (A**2) : 1.200 ; 2.000
REMARK 3 SIDE-CHAIN ANGLE (A**2) : 1.770 ; 2.500
REMARK 3
REMARK 3 BULK SOLVENT MODELING.
REMARK 3 METHOD USED : FLAT MODEL
REMARK 3 KSOL : 0.32
REMARK 3 BSOL : 72.81
REMARK 3
REMARK 3 NCS MODEL : NULL
REMARK 3
REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT
REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL
REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL
REMARK 3
REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.P
REMARK 3 PARAMETER FILE 2 : ACCELRYS_CNX_TOPPAR:WATER_REP.PARAM
REMARK 3 PARAMETER FILE 3 : ACCELRYS_CNX_TOPPAR:ION.PARAM
REMARK 3 PARAMETER FILE 4 : A94.PAR
REMARK 3 PARAMETER FILE 5 : NULL
REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP
REMARK 3 TOPOLOGY FILE 2 : A94.TOP
REMARK 3 TOPOLOGY FILE 3 : NULL
REMARK 3 TOPOLOGY FILE 4 : NULL
REMARK 3 TOPOLOGY FILE 5 : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 2QG0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-JUL-07.
REMARK 100 THE DEPOSITION ID IS D_1000043551.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 24-MAR-06
REMARK 200 TEMPERATURE (KELVIN) : 110.0
REMARK 200 PH : 6.5
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : APS
REMARK 200 BEAMLINE : 17-BM
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.0
REMARK 200 MONOCHROMATOR : SI
REMARK 200 OPTICS : MIRRORS
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000
REMARK 200 DATA SCALING SOFTWARE : HKL-2000
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 45919
REMARK 200 RESOLUTION RANGE HIGH (A) : 1.850
REMARK 200 RESOLUTION RANGE LOW (A) : 20.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 98.5
REMARK 200 DATA REDUNDANCY : 3.200
REMARK 200 R MERGE (I) : NULL
REMARK 200 R SYM (I) : 0.04400
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 27.7000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.85
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.92
REMARK 200 COMPLETENESS FOR SHELL (%) : 93.7
REMARK 200 DATA REDUNDANCY IN SHELL : 3.10
REMARK 200 R MERGE FOR SHELL (I) : NULL
REMARK 200 R SYM FOR SHELL (I) : 0.09600
REMARK 200 <I/SIGMA(I)> FOR SHELL : 12.80
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: CNS
REMARK 200 STARTING MODEL: PDB ENTRY 1YER
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 59.02
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.00
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 40 MG/ML PROTEIN WITH A RESERVOIR
REMARK 280 SOLUTION OF 20-28 %(W/V)PEG 3350, 0.1 M BIS-TRIS-PROPANE PH 6.5,
REMARK 280 0.2 M SODIUM CHLORIDE, VAPOR DIFFUSION, HANGING DROP,
REMARK 280 TEMPERATURE 277K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,Y,-Z
REMARK 290 3555 X+1/2,Y+1/2,Z
REMARK 290 4555 -X+1/2,Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 56.67300
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 44.57200
REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 56.67300
REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 44.57200
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS
REMARK 500
REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC
REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15
REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A
REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375
REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE
REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS.
REMARK 500
REMARK 500 DISTANCE CUTOFF:
REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS
REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE
REMARK 500 O HOH A 2394 O HOH A 2394 2555 2.18
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 ALA A 111 -126.14 52.11
REMARK 500 ALA A 166 -141.36 73.43
REMARK 500 ALA B 111 -132.29 51.95
REMARK 500 ALA B 166 -143.44 68.13
REMARK 500 THR B 176 -36.17 -138.69
REMARK 500 ARG B 182 138.88 -173.09
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE A94 A 2001
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE A94 B 2002
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 2QF6 RELATED DB: PDB
REMARK 900 RELATED ID: 2QFO RELATED DB: PDB
DBREF 2QG0 A 17 223 UNP P07900 HS90A_HUMAN 17 223
DBREF 2QG0 B 17 223 UNP P07900 HS90A_HUMAN 17 223
SEQRES 1 A 207 VAL GLU THR PHE ALA PHE GLN ALA GLU ILE ALA GLN LEU
SEQRES 2 A 207 MET SER LEU ILE ILE ASN THR PHE TYR SER ASN LYS GLU
SEQRES 3 A 207 ILE PHE LEU ARG GLU LEU ILE SER ASN SER SER ASP ALA
SEQRES 4 A 207 LEU ASP LYS ILE ARG TYR GLU SER LEU THR ASP PRO SER
SEQRES 5 A 207 LYS LEU ASP SER GLY LYS GLU LEU HIS ILE ASN LEU ILE
SEQRES 6 A 207 PRO ASN LYS GLN ASP ARG THR LEU THR ILE VAL ASP THR
SEQRES 7 A 207 GLY ILE GLY MET THR LYS ALA ASP LEU ILE ASN ASN LEU
SEQRES 8 A 207 GLY THR ILE ALA LYS SER GLY THR LYS ALA PHE MET GLU
SEQRES 9 A 207 ALA LEU GLN ALA GLY ALA ASP ILE SER MET ILE GLY GLN
SEQRES 10 A 207 PHE GLY VAL GLY PHE TYR SER ALA TYR LEU VAL ALA GLU
SEQRES 11 A 207 LYS VAL THR VAL ILE THR LYS HIS ASN ASP ASP GLU GLN
SEQRES 12 A 207 TYR ALA TRP GLU SER SER ALA GLY GLY SER PHE THR VAL
SEQRES 13 A 207 ARG THR ASP THR GLY GLU PRO MET GLY ARG GLY THR LYS
SEQRES 14 A 207 VAL ILE LEU HIS LEU LYS GLU ASP GLN THR GLU TYR LEU
SEQRES 15 A 207 GLU GLU ARG ARG ILE LYS GLU ILE VAL LYS LYS HIS SER
SEQRES 16 A 207 GLN PHE ILE GLY TYR PRO ILE THR LEU PHE VAL GLU
SEQRES 1 B 207 VAL GLU THR PHE ALA PHE GLN ALA GLU ILE ALA GLN LEU
SEQRES 2 B 207 MET SER LEU ILE ILE ASN THR PHE TYR SER ASN LYS GLU
SEQRES 3 B 207 ILE PHE LEU ARG GLU LEU ILE SER ASN SER SER ASP ALA
SEQRES 4 B 207 LEU ASP LYS ILE ARG TYR GLU SER LEU THR ASP PRO SER
SEQRES 5 B 207 LYS LEU ASP SER GLY LYS GLU LEU HIS ILE ASN LEU ILE
SEQRES 6 B 207 PRO ASN LYS GLN ASP ARG THR LEU THR ILE VAL ASP THR
SEQRES 7 B 207 GLY ILE GLY MET THR LYS ALA ASP LEU ILE ASN ASN LEU
SEQRES 8 B 207 GLY THR ILE ALA LYS SER GLY THR LYS ALA PHE MET GLU
SEQRES 9 B 207 ALA LEU GLN ALA GLY ALA ASP ILE SER MET ILE GLY GLN
SEQRES 10 B 207 PHE GLY VAL GLY PHE TYR SER ALA TYR LEU VAL ALA GLU
SEQRES 11 B 207 LYS VAL THR VAL ILE THR LYS HIS ASN ASP ASP GLU GLN
SEQRES 12 B 207 TYR ALA TRP GLU SER SER ALA GLY GLY SER PHE THR VAL
SEQRES 13 B 207 ARG THR ASP THR GLY GLU PRO MET GLY ARG GLY THR LYS
SEQRES 14 B 207 VAL ILE LEU HIS LEU LYS GLU ASP GLN THR GLU TYR LEU
SEQRES 15 B 207 GLU GLU ARG ARG ILE LYS GLU ILE VAL LYS LYS HIS SER
SEQRES 16 B 207 GLN PHE ILE GLY TYR PRO ILE THR LEU PHE VAL GLU
HET A94 A2001 27
HET A94 B2002 27
HETNAM A94 N-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)METHYL]-3-{[(E)-(2-
HETNAM 2 A94 OXODIHYDROFURAN-3(2H)-YLIDENE)
HETNAM 3 A94 METHYL]AMINO}BENZENESULFONAMIDE
FORMUL 3 A94 2(C17 H19 N5 O4 S)
FORMUL 5 HOH *1131(H2 O)
HELIX 1 1 GLN A 23 THR A 36 1 14
HELIX 2 2 GLU A 42 ASP A 66 1 25
HELIX 3 3 PRO A 67 ASP A 71 5 5
HELIX 4 4 THR A 99 THR A 109 1 11
HELIX 5 5 GLY A 114 ALA A 124 1 11
HELIX 6 6 ASP A 127 GLY A 135 5 9
HELIX 7 7 VAL A 136 LEU A 143 5 8
HELIX 8 8 GLU A 192 LEU A 198 5 7
HELIX 9 9 GLU A 199 SER A 211 1 13
HELIX 10 10 GLN B 23 THR B 36 1 14
HELIX 11 11 GLU B 42 ASP B 66 1 25
HELIX 12 12 PRO B 67 ASP B 71 5 5
HELIX 13 13 THR B 99 THR B 109 1 11
HELIX 14 14 GLY B 114 GLN B 123 1 10
HELIX 15 15 ASP B 127 GLY B 135 5 9
HELIX 16 16 VAL B 136 LEU B 143 5 8
HELIX 17 17 GLU B 192 LEU B 198 5 7
HELIX 18 18 GLU B 199 SER B 211 1 13
SHEET 1 A 8 GLU A 18 ALA A 21 0
SHEET 2 A 8 SER A 169 THR A 174 -1 O PHE A 170 N PHE A 20
SHEET 3 A 8 TYR A 160 SER A 164 -1 N ALA A 161 O ARG A 173
SHEET 4 A 8 ALA A 145 LYS A 153 -1 N VAL A 150 O TRP A 162
SHEET 5 A 8 GLY A 183 LEU A 190 -1 O ILE A 187 N THR A 149
SHEET 6 A 8 THR A 88 ASP A 93 -1 N ILE A 91 O VAL A 186
SHEET 7 A 8 ILE A 78 ASN A 83 -1 N ASN A 79 O VAL A 92
SHEET 8 A 8 ILE A 218 LEU A 220 1 O THR A 219 N LEU A 80
SHEET 1 B 8 GLU B 18 ALA B 21 0
SHEET 2 B 8 SER B 169 THR B 174 -1 O PHE B 170 N PHE B 20
SHEET 3 B 8 TYR B 160 SER B 164 -1 N ALA B 161 O ARG B 173
SHEET 4 B 8 ALA B 145 LYS B 153 -1 N VAL B 150 O TRP B 162
SHEET 5 B 8 GLY B 183 LEU B 190 -1 O ILE B 187 N THR B 149
SHEET 6 B 8 THR B 88 ASP B 93 -1 N ILE B 91 O VAL B 186
SHEET 7 B 8 ILE B 78 ASN B 83 -1 N ASN B 79 O VAL B 92
SHEET 8 B 8 ILE B 218 LEU B 220 1 O THR B 219 N LEU B 80
SITE 1 AC1 19 ASN A 51 ASP A 54 ALA A 55 LYS A 58
SITE 2 AC1 19 ASP A 93 ILE A 96 GLY A 97 MET A 98
SITE 3 AC1 19 ASN A 106 GLY A 135 GLY A 137 PHE A 138
SITE 4 AC1 19 THR A 184 HOH A2002 HOH A2003 HOH A2010
SITE 5 AC1 19 HOH A2053 HOH A2255 HOH A2262
SITE 1 AC2 21 ASN B 51 ASP B 54 ALA B 55 LYS B 58
SITE 2 AC2 21 ASP B 93 ILE B 96 GLY B 97 MET B 98
SITE 3 AC2 21 ASN B 106 GLY B 135 GLY B 137 PHE B 138
SITE 4 AC2 21 TYR B 139 THR B 184 HOH B2004 HOH B2006
SITE 5 AC2 21 HOH B2008 HOH B2011 HOH B2050 HOH B2091
SITE 6 AC2 21 HOH B2098
CRYST1 113.346 89.144 64.456 90.00 121.45 90.00 C 1 2 1 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.008823 0.000000 0.005395 0.00000
SCALE2 0.000000 0.011218 0.000000 0.00000
SCALE3 0.000000 0.000000 0.018186 0.00000